Blood Res.  2021 Dec;56(4):212-214. 10.5045/br.2021.2021140.

Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19

• Jang HR
• Lim KH

• KMID: 2524069
• DOI: http://doi.org/10.5045/br.2021.2021140

Figure

• 

  Fig. 1 Changes in the platelet count before and after ChAdOx1 nCov-19 vaccine. Blue squared area: normal reference range of platelet count.

Reference

1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. 2020; Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 324:782–93. DOI: 10.1001/jama.2020.12839. PMID: 32648899.

2. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. 2021; Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 384:2092–101. DOI: 10.1056/NEJMoa2104840. PMID: 33835769. PMCID: PMC8095372.

3. Schultz NH, Sørvoll IH, Michelsen AE, et al. 2021; Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 384:2124–30. DOI: 10.1056/NEJMoa2104882. PMID: 33835768. PMCID: PMC8112568.

4. Pottegård A, Lund LC, Karlstad Ø, et al. 2021; Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 373:n1114. DOI: 10.1136/bmj.n1114. PMID: 33952445. PMCID: PMC8097496.

5. Scully M, Singh D, Lown R, et al. 2021; Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 384:2202–11. DOI: 10.1056/NEJMoa2105385. PMID: 33861525. PMCID: PMC8112532.

6. Thiele T, Ulm L, Holtfreter S, et al. 2021; Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2. Blood. 138:299–303. DOI: 10.1182/blood.2021012217. PMID: 33988688. PMCID: PMC8129797.

7. Kuter DJ. 2021; Exacerbation of immune thrombocytopenia following COVID-19 vaccination. Br J Haematol. 195:365–70. DOI: 10.1111/bjh.17645. PMID: 34075578. PMCID: PMC8239625.